From the Leibniz-Institut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125 Berlin and.
From the Leibniz-Institut für Molekulare Pharmakologie (FMP), Robert-Rössle-Strasse 10, 13125 Berlin and
J Biol Chem. 2018 Feb 2;293(5):1526-1535. doi: 10.1074/jbc.R117.000629. Epub 2017 Dec 27.
Phosphoinositides (PIs) are phospholipids that perform crucial cell functions, ranging from cell migration and signaling to membrane trafficking, by serving as signposts of compartmental membrane identity. Although phosphatidylinositol 4,5-bisphosphate, 3-phosphate, and 3,5-bisphosphate are commonly considered as hallmarks of the plasma membrane, endosomes, and lysosomes, these compartments contain other functionally important PIs. Here, we review the roles of PIs in different compartments of the endolysosomal system in mammalian cells and discuss the mechanisms that spatiotemporally control PI conversion in endocytosis and endolysosomal membrane dynamics during endosome maturation and sorting. As defective PI conversion underlies human genetic diseases, including inherited myopathies, neurological disorders, and cancer, PI-converting enzymes represent potential targets for drug-based therapies.
磷脂酰肌醇(PI)是一类重要的磷脂,通过充当区室膜特征的标记物,参与细胞迁移和信号转导、膜运输等多种细胞功能。尽管磷酸肌醇 4,5-二磷酸、3-磷酸和 3,5-二磷酸通常被认为是质膜、内体和溶酶体的标志,但这些区室还包含其他具有重要功能的 PI。本文综述了哺乳动物细胞内吞体-溶酶体系统不同区室中 PI 的作用,并讨论了在内涵体成熟和分选过程中,控制 PI 转化的时空机制,以及 PI 转化对质膜动力学的影响。由于人类遗传疾病(包括遗传性肌病、神经紊乱和癌症)的发生与 PI 转化缺陷有关,PI 转化酶是药物治疗的潜在靶点。